| Company/Division name | Siemens Healthineers |
| Type of work | Manufacturing |
| Reshoring category: | Foreign Direct Investment |
| Total number of jobs (added or to be added): | 700 |
| Year reshoring announced: | 2017 |
| Year reshoring implemented or to be implemented: | 2027 |
| Domestically, the work will be done: | In-house |
| Capital investment ($): | 300 |
| Country(ies) from which reshored: | Germany |
| City reshored to: | Wapole |
| State(s) reshored to: | MA |
| If relevant, work nearshored to: | - |
| Industry(ies): | Medical Equipment & Supplies, healthcare |
| Product(s) reshored | laboratory diagnostics |
| What domestic positive factors made reshoring more attractive? | Proximity to customers/market, creating local value in the U.S. |
